Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some of its $215 million war chest to assess monthly dosing of the injectable therapy.